A socially oriented non-financial development institution and a major organizer of nationwide and international conventions; exhibitions; and business, public, youth, sporting, and cultural events.

The Roscongress Foundation is a socially oriented non-financial development institution and a major organizer of nationwide and international conventions; exhibitions; and business, public, youth, sporting, and cultural events. It was established in pursuance of a decision by the President of the Russian Federation.

The Foundation was established in 2007 with the aim of facilitating the development of Russia’s economic potential, promoting its national interests, and strengthening the country’s image. One of the roles of the Foundation is to comprehensively evaluate, analyse, and cover issues on the Russian and global economic agendas. It also offers administrative services, provides promotional support for business projects and attracting investment, helps foster social entrepreneurship and charitable initiatives.

Each year, the Foundation’s events draw participants from 208 countries and territories, with more than 15,000 media representatives working on-site at Roscongress’ various venues. The Foundation benefits from analytical and professional expertise provided by 5,000 people working in Russia and abroad.

The Foundation works alongside various UN departments and other international organizations, and is building multi-format cooperation with 173 economic partners, including industrialists’ and entrepreneurs’ unions, financial, trade, and business associations from 78 countries worldwide, and 179 Russian public organizations, federal and legislative agencies, and federal subjects.

The Roscongress Foundation has Telegram channels in Russian t.me/Roscongress, English – t.me/RoscongressDirect, and Spanish t.me/RoscongressEsp. Official website and Information and Analytical System of the Roscongress Foundation: roscongress.org.

RC personal account
Восстановление пароля
Введите адрес электронной почты или телефон, указанные при регистрации. Вам будет отправлена инструкция по восстановлению пароля.
Некорректный формат электронной почты или телефона
Aleksandr Petrov

Aleksandr Petrov

Chairman of the Subcommittee on Medicines, Development of the Pharmaceutical and Medical Industry, Committee of the State Duma of the Federal Assembly of the Russian Federation on Health Protection
Quotes
16.06.2022
SPIEF 2022
Replacing Imports with Domestic Alternatives in Healthcare: New Areas of Growth
We need to start with numbers. Medications are pure math – the number of patients that require a certain medication. <…> We are busy with our 2023 budget and are adjusting the 2024–2025 budget. The Ministry of Finance says they will allocate RUB 10 bln [for the prevention of cardiovascular diseases, – Ed.]. It is a lot or not? No one can say
16.06.2022
SPIEF 2022
Replacing Imports with Domestic Alternatives in Healthcare: New Areas of Growth
The number one issue is people’s trust in domestically produced medications and medications imported from partner countries. Trust is a fundamental thing
16.06.2022
SPIEF 2022
Replacing Imports with Domestic Alternatives in Healthcare: New Areas of Growth
Everyone perceives import substitution as catching up. I think we found a term that will be widely used, if our colleagues from the government would not mind. It is import independence. I think this term describes what we want to achieve better. However, can we [substitute, – Ed.] all the medications? No, not a single country in the world is capable of that. But are we isolated? No
02.09.2021
EEF 2021
Partnership Against the Pandemic: Anti-Crisis Strategies in Medicine
The pandemic has shown that without the centralization of healthcare and the Medical Insurance Fund, we are weak. You are very good people, very active in your regions. I am sure you won’t find a single region with the same insurance rates for the same standard of medical care. This is a good question, but the federal fund is only giving recommendations today
05.06.2021
SPIEF 2021
Healthcare as Investment: Public and Private Partnership in the Pharmaceutical Sector
We need to coordinate actions and have regulatory programmes for special circumstances, when the pharmaceutical companies, whether they are publicly or privately owned, must get a registration package from the government to produce certain drugs in order to have those available in Russia
05.06.2021
SPIEF 2021
Healthcare as Investment: Public and Private Partnership in the Pharmaceutical Sector
Each region creates its own system. And, honestly, a huge number of regions are failing
05.06.2021
SPIEF 2021
Healthcare as Investment: Public and Private Partnership in the Pharmaceutical Sector
If you take a look at the legislation <...> there are a lot of changes in terms of medicines and supplies. I am sure that this is the right thing, but what do we do to make the legislation more harmonious? This is a serious challenge today, even for me, although, after doing this professionally for 10 years, I certainly have a better understanding of it
08.06.2019
SPIEF 2019
Priority Strategies in the Supply of Drugs
What is of greatest concern in Russian society? What is the most important issue? It is the need for fairness. The electorate are wondering why one person is able to receive a particular drug, while another is not
13.02.2019
Healthy Life Forum: Towards 80+ 2019
A System of Universal Medicine Provision: Key to Achieving the National Goal
A lot has been done recently to make medicines accessible to the population. After the industrial policy legislation that we had been dreaming of passed (it was 10 years in the making), the Ministry of Industry and Trade took the most important step through the Industry Development Fund. We went from pushing paper to financing industries